US Markets

Health Care Sector Update for 09/24/2019: URGN,NEOG,AIM,ADPT

Top Health Care Stocks

JNJ -0.02%

PFE -0.59%

ABT -0.90%

MRK -1.04%

AMGN -0.59%

Health care stocks ended lower on Tuesday, with the NYSE Health Care Index falling 0.7% while the shares of health care companies in the S&P 500 fell 0.9% as a group. The Nasdaq Biotechnology index tumbled 2%.

Among health care stocks moving on news:

(-) UroGen Pharma (URGN) fell 1.5%, bouncing back from an early 10.2% drop to a new 23-month low of $29.73 a share, after announcing encouraging results from a late-stage trial of its UGN-101 drug candidate, with the mitomycin gel demonstrating a 59% complete response rate in patients with low-grade upper tract urothelial cancer. Based on the positive results, the company said it is expecting to complete the new drug application for UGN-101 for submission to the US Food and Drug Adminstration before the end of the year.

In other sector news:

(+) AIM ImmunoTech (AIM) tumbled 15%. The company announced a $8.32 million funding grant from the US Department of Defense on Tuesday. The Pentagon breakthrough award will fund phase II testing of a combination of therapies, including the company's Ampligen drug candidate, in patients with brain-metastatic breast cancer.

(-) Adaptive Biotechnologies (ADPT) declined 7.8% this afternoon. The biotechnology company Tuesday announced a new partnership with Illumina (ILMN) to develop in-vitro diagnostic test kits for next-generation sequencing-based immunodiagnostics.

(-) Neogen (NEOG) dropped almost 12% on Tuesday after the diagnostic test kits company reported fiscal Q1 net income of $0.28 per share, slipping from a $0.29 per share profit during the same quarter last year and trailing the Capital IQ consensus for the three months ended August 31 by $0.02 per share. Revenue grew 1.8% year-over-year to $101.4 million, also lagging the $105.2 million Street view.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

URGN NEOG AIM ADPT